RIP140 increases APC expression and controls intestinal homeostasis and tumorigenesis

Area of Science:

• Molecular Biology
• Cancer Research
• Gastroenterology

Background:

• Wnt/APC/β-catenin signaling pathway deregulation is a hallmark of colorectal cancer.
• Tumor suppressor APC dysfunction is a key driver of this pathway disruption.
• Understanding regulators of intestinal homeostasis is crucial for cancer prevention.

Purpose of the Study:

• To investigate the role of transcriptional coregulator RIP140 in intestinal homeostasis and tumorigenesis.
• To determine RIP140's impact on intestinal epithelial cell proliferation, apoptosis, and regeneration.
• To elucidate RIP140's mechanism in regulating the Wnt/APC/β-catenin pathway in colon cancer.

Main Methods:

• Utilized Rip140-null and RIP140-overexpressing mice models.
• Assessed intestinal regenerative capacity post-irradiation.
• Evaluated RIP140's effect on human colon cancer cell proliferation in vitro and in vivo.
• Analyzed RIP140's regulation of APC transcription and β-catenin signaling.
• Compared RIP140 expression levels in human colon cancer tissues versus normal tissues.

Main Results:

• RIP140 deficiency improved intestinal regeneration after irradiation, while overexpression impaired it.
• RIP140 suppressed colon cancer cell proliferation in vitro and in vivo.
• RIP140 enhanced APC transcription and inhibited β-catenin activation.
• RIP140 mRNA and protein levels were significantly decreased in human colon cancers.
• Low RIP140 expression correlated with poor prognosis in colon adenocarcinoma patients.

Conclusions:

• RIP140 plays a critical role in maintaining intestinal homeostasis and suppressing colon tumorigenesis.
• RIP140 functions as a tumor suppressor by modulating the Wnt/APC/β-catenin pathway.
• Decreased RIP140 expression is a potential biomarker for poor prognosis in colorectal cancer.